Cebon J - Search Results

1

Exogenous peptides presented by transporter associated with antigen processing (TAP)-deficient and TAP-competent cells: intracellular loading and kinetics of presentation.

Luft T, Rizkalla M, Tai TY, Chen Q, MacFarlan RI, Davis ID, Maraskovsky E, Cebon J. Luft T, et al. Among authors: cebon j. J Immunol. 2001 Sep 1;167(5):2529-37. doi: 10.4049/jimmunol.167.5.2529. J Immunol. 2001. PMID: 11509592

2

Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1.

Campbell IK, Novak U, Cebon J, Layton JE, Hamilton JA. Campbell IK, et al. Among authors: cebon j. J Immunol. 1991 Aug 15;147(4):1238-46. J Immunol. 1991. PMID: 1714478

3

Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice.

Basu S, Dunn AR, Marino MW, Savoia H, Hodgson G, Lieschke GJ, Cebon J. Basu S, et al. Among authors: cebon j. J Immunol. 1997 Aug 1;159(3):1412-7. J Immunol. 1997. PMID: 9233638

4

A serum-free culture model for studying the differentiation of human dendritic cells from adult CD34+ progenitor cells.

Luft T, Pang KC, Thomas E, Bradley CJ, Savoia H, Trapani J, Cebon J. Luft T, et al. Among authors: cebon j. Exp Hematol. 1998 Jun;26(6):489-500. Exp Hematol. 1998. PMID: 9620282

5

Type I IFNs enhance the terminal differentiation of dendritic cells.

Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, Trapani J, Cebon J. Luft T, et al. Among authors: cebon j. J Immunol. 1998 Aug 15;161(4):1947-53. J Immunol. 1998. PMID: 9712065

6

Spontaneous T cell responses to melanoma differentiation antigens from melanoma patients and healthy subjects.

Chen Q, Jackson H, Gibbs P, Davis ID, Trapani J, Cebon J. Chen Q, et al. Among authors: cebon j. Cancer Immunol Immunother. 1998 Dec;47(4):191-7. doi: 10.1007/s002620050520. Cancer Immunol Immunother. 1998. PMID: 9875671 Free PMC article.

7

An HLA-A2 polyepitope vaccine for melanoma immunotherapy.

Mateo L, Gardner J, Chen Q, Schmidt C, Down M, Elliott SL, Pye SJ, Firat H, Lemonnier FA, Cebon J, Suhrbier A. Mateo L, et al. Among authors: cebon j. J Immunol. 1999 Oct 1;163(7):4058-63. J Immunol. 1999. PMID: 10491010

8

A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A27-35 and Melan-A26-35.

Chen Q, Jackson H, Cebon J, Gibbs P, Davis ID, Trapani JA. Chen Q, et al. Among authors: cebon j. Melanoma Res. 2000 Feb;10(1):16-25. Melanoma Res. 2000. PMID: 10711636

9

A phase I and pharmacokinetic study of subcutaneously-administered recombinant human interleukin-4 (rhuIL-4) in patients with advanced cancer.

Davis ID, Maher DW, Cebon JS, Green MD, Fox RM, McKendrick JJ, Rybak ME, Boyd AW. Davis ID, et al. Among authors: cebon js. Growth Factors. 2000;17(4):287-300. doi: 10.3109/08977190009028972. Growth Factors. 2000. PMID: 10801077 Clinical Trial.

10

MAGE-12 and MAGE-6 are frequently expressed in malignant melanoma.

Gibbs P, Hutchins AM, Dorian KT, Vaughan HA, Davis ID, Silvapulle M, Cebon JS. Gibbs P, et al. Among authors: cebon js. Melanoma Res. 2000 Jun;10(3):259-64. Melanoma Res. 2000. PMID: 10890380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters